Maintaining Integrity: Mastering the Chinese Wall and Need-to-Know Principle
Imagine you are an analyst covering the pharmaceutical sector. You are currently deep in the weeds of a valuation model for a large-cap company, while your colleague in the investment banking division is simultaneously...